Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine + propofol vs sufentanil + propofol for painless gastroscopy
ChiCTR2400092206Phase 4Not yet recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in procedural pain (2 arms), sponsored by Henan Cancer Hospital. Primary endpoints: Respiratory-related adverse reactions and Pain score. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2400092206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092206.